echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The Lancet Oncology: Excluding ethnic factors in the assessment of renal function may affect the treatment of black cancer patients

    The Lancet Oncology: Excluding ethnic factors in the assessment of renal function may affect the treatment of black cancer patients

    • Last Update: 2021-08-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    • A retrospective analysis of 340 black cancer patients participating in the first phase of clinical trials in the United States between 1995 and 2010 showed that the number of CKD-EPI equations that exclude race may reduce the number of black cancer patients deemed eligible for resistance.


    • If race is excluded from the CKD-EPI equation, as many as 5% and 18% of patients in the analysis will be excluded from treatment or receive lower dose recommendations


    • The equation of race agnosticism has been proposed, but more work is needed to allow a wide range of clinical applications


    • The results of the study emphasize the need to consider the use of race-based adjustments, careful and precise clinical judgments, and patient-centered methods to explain and compare the complexity of renal function estimation in different gfr estimation equations


    Elimination of race factors in the kidney function-estimating equation is used to guide cancer treatment doses and qualifications that may reduce the proportion of black patients.


    The Chronic Kidney Disease-Epidemiology Cooperation (CKD-EPI) equation estimates a key indicator of kidney function, called glomerular filtration rate (GFR)


    Since the kidney is the main organ that removes substances from the body, clinicians can use the CKD-EPI equation to help determine the eligibility and dosage of anticancer drugs for cancer patients


    Dr.


    The co-author of the study, Dr.


    The author conducted a retrospective analysis of 340 black patients who were included in the Phase I clinical trial of the National Cancer Institute of the United States from 1995 to 2010


    The CKD-EPI equation was used to estimate the patient's renal function, and race was used as a variable


    The median glomerular filtration rate calculated by CKD-EPI was 103 mL/min, while the median glomerular filtration rate calculated by CKD-EPI without ethnic factors was 89 mL/min


    Since the elimination of race in the CKD-EPI equation reduces the number of patients who are recommended to use or receive full-dose anticancer drugs, the authors admit that doing so may reduce the toxicity of anticancer drugs, but further research is needed


    The authors also admit that their research has some limitations


    Dr.


    DOI 10.


    Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.